PAVmed (PAVM) Change in Receivables (2022 - 2025)
PAVmed's (PAVM) quarterly Change in Receivables came in at $12000.0 in Q4 2025, up 500.0% year-on-year from $2000.0 in Q4 2024, and up 271.43% quarter-over-quarter from -$7000.0 in Q2 2025.
PAVmed (PAVM) Change in Receivables (2022 - 2025) Analysis & Trends
PAVmed's Change in Receivables history runs 4 years deep, the most recent figure standing at $12000.0 for Q4 2025.
- On a quarterly basis, Change in Receivables rose 500.0% year-over-year to $12000.0 in Q4 2025; TTM through Dec 2025 was -$3000.0, a 101.61% decrease from a year earlier, with the FY2025 full-year figure at -$3000.0, up 93.02% from the prior year.
- Change in Receivables advanced to $12000.0 in Q4 2025 per PAVM's latest filing, from -$7000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $152000.0 in Q2 2024 and bottomed at -$111000.0 in Q1 2022.
- The 4-year median for Change in Receivables is $4000.0 (2024), against an average of $1285.7.
- Across the five-year window, Change in Receivables soared 985.71% in 2024 and sank 233.33% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$14000.0 in 2022, then surged by 285.71% to $26000.0 in 2023, then tumbled by 92.31% to $2000.0 in 2024, then jumped by 500.0% to $12000.0 in 2025.
- Per Business Quant, the three latest PAVM Change in Receivables figures stand at $12000.0 (Q4 2025), -$7000.0 (Q2 2025), and -$8000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |